Published on December 1, 2009 at 6:48 AM
Reportlinker.com announces that a new market research report is available in its catalogue: Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response
http://www.reportlinker.com/p0165600/Inflammatory-Disorders-Therapies-That-Suppress-or-Balance-the-Immune-Response.html
The human immune system can go awry, either attacking an individual body or producing an exaggerated response to a foreign substance that is normally benign. In these situations, immunotherapies are needed to balance or suppress the unwarranted immune response. In this report:
- Approximately 400 product candidates and development programs are identified.
- Current and emerging therapies for selected autoimmune or inflammatory disorders and prevention of organ transplant rejection, directed against a wide range of putative targets, are summarized.
- Specifically, more than 250 emerging autoimmune disease therapies, 80 asthma therapies in development, and 50+ therapy candidates for allergies are covered.
- The strategic consequences of intense competition in a crowded product space are considered.
Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response reviews the problems of insufficient efficacy, side effects, and adverse events associated with the small-molecule and biological drugs available today to treat these disorders. These observations have led to an interest in identifying ways to balance the immune reaction, to suppress the part of the immune response that is causing the disease, while maintaining or enhancing other aspects of the immune system. This report identifies nearly 400 ongoing product candidates and development programs in these indication areas. The companies active in these areas range from multinational pharmaceutical companies with a number of active programs to small boutique start-ups working on a very defined topic.
SOURCE Reportlinker
a64cbecd-53fb-41d0-a76f-9bc41ab36c6b|0|.0
Posted in: Medical Condition News | Pharmaceutical News
Tags: Allergy, Anti-Inflammatory, Arthritis, Asthma, Autoimmune Disease, Biotechnology, Crohn's Disease, Diabetes, Diabetes Mellitus, Inflammatory Bowel Disease, Lupus, Multiple Sclerosis, Pfizer, Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Transplant, Type 1 Diabetes, Ulcerative Colitis